Keywords: gs, analysts, trim, eps, forecasts, bayer, although

GS Analysts Trim EPS Forecasts For Bayer

Article | 03 September 1998

Print This

Although analysts at Goldman Sachs are retaining their market performerrating for German drug major Bayer, they are trimming their earnings ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in